172 related articles for article (PubMed ID: 22269836)
21. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
22. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
23. [CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Institute for Quality Assurance].
van Ballegooie E; van Everdingen JJ
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):413-8. PubMed ID: 10719544
[TBL] [Abstract][Full Text] [Related]
24. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
[TBL] [Abstract][Full Text] [Related]
25. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
[TBL] [Abstract][Full Text] [Related]
26. [Occult chronic kidney disease (OCKD), and cardiovascular risk factors. Epidemiologic study].
Otero A; Abelleira A; Gayoso P
Nefrologia; 2005; 25(3):275-87. PubMed ID: 16053009
[TBL] [Abstract][Full Text] [Related]
27. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029
[No Abstract] [Full Text] [Related]
28. [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa Uva M; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL;
Kardiol Pol; 2013; 71 Suppl 11():S319-94. PubMed ID: 24297732
[No Abstract] [Full Text] [Related]
29. Diabetes, cardiovascular risk and nephropathy.
Hahr AJ; Molitch ME
Cardiol Clin; 2010 Aug; 28(3):467-75. PubMed ID: 20621251
[TBL] [Abstract][Full Text] [Related]
30. Clothing size as an indicator of adiposity, ischaemic heart disease and cardiovascular risks.
Han TS; Gates E; Truscott E; Lean ME
J Hum Nutr Diet; 2005 Dec; 18(6):423-30. PubMed ID: 16351701
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay.
Jimenez JT; Palacios M; Cañete F; Barriocanal LA; Medina U; Figueredo R; Martinez S; de Melgarejo MV; Weik S; Kiefer R; Alberti KG; Moreno-Azorero R
Diabet Med; 1998 Apr; 15(4):334-8. PubMed ID: 9585400
[TBL] [Abstract][Full Text] [Related]
32. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
Saha SA; Tuttle KR
Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
[TBL] [Abstract][Full Text] [Related]
33. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
Nielsen FS
Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829
[No Abstract] [Full Text] [Related]
34. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
Folan LA; Tuttle KR
Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
[TBL] [Abstract][Full Text] [Related]
35. The need for tighter control of cardiovascular risk factors in diabetic patients.
Viberti G
J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hypertension in patients with diabetes.
Sowers JR
Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759
[TBL] [Abstract][Full Text] [Related]
37. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
Kim KI; Kim CH
Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
[TBL] [Abstract][Full Text] [Related]
38. Renal involvement and left ventricular hypertrophy are novel risk factors for morbidity and mortality in diabetes mellitus.
Boner G
Diabetes Metab Res Rev; 2011 Jul; 27(5):425-9. PubMed ID: 21432982
[TBL] [Abstract][Full Text] [Related]
39. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
[TBL] [Abstract][Full Text] [Related]
40. [Diabetes mellitus and cardiovascular risk].
Valdés F; Lorenzo D; Calviño X; Cao M; Fernández Rivera C; Pérez Fontán M
Nefrologia; 2001; 21 Suppl 3():52-7. PubMed ID: 11642208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
